Abstract
The quality-adjusted life-year (QALY) is used to measure outcome in rheumatoid arthritis (RA) studies; identification of drivers of a gain in QALY might help predict a treatment response. We investigated how changes in components of the Disease Activity Score-28 joints (DAS28) were associated with the European League Against Rheumatism (EULAR) and European Quality of Life 5 Dimensions (EQ-5D) responses; and what baseline variables predicted the change in QALY following 1 year of biological therapy.
| Original language | English |
|---|---|
| Journal | Journal of Rheumatology |
| Volume | 40 |
| Issue number | 9 |
| Pages (from-to) | 1479-86 |
| Number of pages | 8 |
| ISSN | 0315-162X |
| DOIs | |
| Publication status | Published - Sept 2013 |